These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 36559052)

  • 21. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications.
    Jansook P; Ogawa N; Loftsson T
    Int J Pharm; 2018 Jan; 535(1-2):272-284. PubMed ID: 29138045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes.
    Loftsson T; Brewster ME
    J Pharm Pharmacol; 2011 Sep; 63(9):1119-35. PubMed ID: 21827484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclodextrin complexes: Perspective from drug delivery and formulation.
    Jacob S; Nair AB
    Drug Dev Res; 2018 Aug; 79(5):201-217. PubMed ID: 30188584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inclusion Solves Insolubility -Translational Research Cycle from Bedside to Bench and Bench to Bedside for Drug Development Targeting Niemann-Pick Disease Type C].
    Irie T
    Yakugaku Zasshi; 2022; 142(4):389-400. PubMed ID: 35370195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies.
    Santos AC; Costa D; Ferreira L; Guerra C; Pereira-Silva M; Pereira I; Peixoto D; Ferreira NR; Veiga F
    Drug Deliv Transl Res; 2021 Feb; 11(1):49-71. PubMed ID: 32441011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cyclodextrins in ophthalmics.
    Kaur IP; Chhabra S; Aggarwal D
    Curr Drug Deliv; 2004 Oct; 1(4):351-60. PubMed ID: 16305397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effects on rabbit corneal epithelium.
    Jansen T; Xhonneux B; Mesens J; Borgers M
    Lens Eye Toxic Res; 1990; 7(3-4):459-68. PubMed ID: 2100172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclodextrins in Parenteral Formulations.
    Loftsson T
    J Pharm Sci; 2021 Feb; 110(2):654-664. PubMed ID: 33069709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclodextrin-based delivery systems in parenteral formulations: A critical update review.
    Ferreira L; Campos J; Veiga F; Cardoso C; Paiva-Santos AC
    Eur J Pharm Biopharm; 2022 Sep; 178():35-52. PubMed ID: 35868490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring versatile applications of cyclodextrins: an overview.
    Sharma N; Baldi A
    Drug Deliv; 2016; 23(3):739-57. PubMed ID: 25051096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclodextrins Exert a Ligand-like Current Inhibitory Effect on the K
    Kovacs T; Sohajda T; Szente L; Nagy P; Panyi G; Varga Z; Zakany F
    Front Mol Biosci; 2021; 8():735357. PubMed ID: 34805269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
    Loftsson T; Brewster ME
    J Pharm Sci; 2012 Sep; 101(9):3019-32. PubMed ID: 22334484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cyclodextrins on drug delivery through biological membranes.
    Loftsson T; Vogensen SB; Brewster ME; Konrádsdóttir F
    J Pharm Sci; 2007 Oct; 96(10):2532-46. PubMed ID: 17630644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
    Muankaew C; Loftsson T
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physicochemical characterization of cyclodextrin-drug interactions in the solid state and the effect of water on these interactions.
    Ogawa N; Takahashi C; Yamamoto H
    J Pharm Sci; 2015 Mar; 104(3):942-54. PubMed ID: 25581322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update for nurse anesthetists--part 3--cyclodextrin introduction to anesthesia practice: form, function, and application.
    Welliver M
    AANA J; 2007 Aug; 75(4):289-96. PubMed ID: 17711159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of cyclodextrins as excipients in pharmaceutical products: why not in extemporaneous preparations?
    Ramos-Martínez B; Dávila-Pousa C; Merino-Bohórquez V; García-Palomo M; Flox-Benítez MªP
    Farm Hosp; 2021 Nov; 46(1):31-39. PubMed ID: 35379090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Force Field Parameterization for the Description of the Interactions between Hydroxypropyl-β-Cyclodextrin and Proteins.
    Arsiccio A; Rospiccio M; Shea JE; Pisano R
    J Phys Chem B; 2021 Jul; 125(27):7397-7405. PubMed ID: 34210121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.
    Loftsson T; Stefánsson E
    Acta Ophthalmol Scand; 2002 Apr; 80(2):144-50. PubMed ID: 11952479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. γ-Cyclodextrin.
    Saokham P; Loftsson T
    Int J Pharm; 2017 Jan; 516(1-2):278-292. PubMed ID: 27989822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.